Question-based Drug Development for psilocybin - Authors' reply.
Robin Carhart-Harris, David Nutt
Lancet Psychiatry September 1, 2016 DOI: 10.1016/s2215-0366(16)30217-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Psychedelic therapy:psilocybin therapy Psychedelic medicine Therapeutic psychedelics Novel therapies Mental health treatment Drug development:pharmaceutical development Research and development R&d Drug discovery Medical product development Therapeutic development Drug pipeline Research methodology:development strategy Scientific method Research approach Clinical research methods Systematic inquiry Question-based method Development framework Study phases Development stages Research phases Clinical trials:clinical research Human trials Drug testing Trial phases Clinical phases |
| Citations | 1 |
| Key points | The authors address questions and comments regarding their approach to drug development for psilocybin. |
Abstract
Question-based Drug Development for psilocybin - Authors' reply.